HAVCR2 and neoplasm: Consistently, as shown in Figure 2A, TCF-1+TIM-3–PD-1+CD8+ progenitor Tex expanded after anti–PD-1 treatment early on, when encountering tumor cells, and then progressively differentiated into TCF-1–TIM-3+PD-1+CD8+ terminal Tex.